What does being heterozygous for the p.Cys282Tyr (C282Y) variant in the HFE gene indicate?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 4, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Heterozygous p.Cys282Tyr (C282Y) HFE Variant

Being heterozygous for the p.Cys282Tyr (C282Y) HFE variant means you carry one copy of the most common hemochromatosis mutation, which generally does NOT cause clinically significant iron overload or require treatment. 1

What This Genotype Means

  • C282Y heterozygotes (one mutant copy, one normal copy) are extremely common, affecting approximately 10% of the general Caucasian population 2
  • These individuals do NOT develop progressive or symptomatic iron overload and can be reassured they are not at risk for hemochromatosis 1
  • Iron absorption is NOT significantly increased in C282Y heterozygotes compared to individuals with two normal HFE genes 3

Iron Parameters in Heterozygotes

While C282Y heterozygotes show slightly elevated mean values for certain iron markers compared to wild-type individuals, these differences are subtle: 4, 5

  • Transferrin saturation: Mildly increased but typically remains within or near normal range
  • Serum ferritin: Slightly elevated on average but not clinically significant
  • Hemoglobin: Marginally higher, potentially offering mild protection against iron deficiency in young women 5

Importantly, C282Y heterozygotes do NOT differ meaningfully from wild-type individuals in terms of serum iron tests when selected from family studies 2

Clinical Implications and Follow-Up

C282Y heterozygotes do NOT require special monitoring or treatment for hemochromatosis 1, 2

When to Investigate Further

If a C282Y heterozygote presents with abnormal iron studies (elevated transferrin saturation and ferritin), you must investigate for: 2

  • Other causes of iron overload (secondary causes, other liver diseases)
  • Rare second HFE mutations in trans (on the other chromosome) 6
  • Compound heterozygosity with H63D variant (C282Y/H63D), which can cause mild iron overload 1, 2

Algorithm for elevated iron studies in C282Y heterozygotes: 6

  1. Confirm elevated transferrin saturation (>45% in females, >50% in males) AND elevated ferritin
  2. Test for H63D variant to rule out compound heterozygosity
  3. If hepatic iron index is elevated, consider sequencing entire HFE gene for rare mutations
  4. Evaluate for secondary causes: alcohol use, viral hepatitis, fatty liver disease, iron-loading anemias 1

Role as a Cofactor

C282Y heterozygosity can act as a cofactor that worsens iron accumulation when combined with other liver diseases: 1

  • Porphyria cutanea tarda (PCT)
  • Hepatitis C infection
  • Alcoholic liver disease
  • Non-alcoholic fatty liver disease (NAFLD)

Family Screening Considerations

If you are a C282Y heterozygote, your children's risk depends on your partner's genotype: 1

  • If your partner has normal HFE genes, your children will be either heterozygotes (no risk) or have normal genes
  • If your partner is also a C282Y heterozygote, each child has a 25% chance of being a C282Y homozygote (at risk for hemochromatosis)
  • Testing your partner is recommended before testing children 1

Common Pitfalls

  • Do NOT confuse heterozygosity with homozygosity: C282Y/C282Y homozygotes (two mutant copies) have 80-90% of hereditary hemochromatosis cases and DO require monitoring and treatment 1
  • Do NOT attribute elevated ferritin solely to C282Y heterozygosity: Ferritin elevation is strongly associated with obesity, metabolic syndrome, inflammation, and other liver diseases 2
  • Do NOT order iron fortification restrictions: C282Y heterozygotes absorb dietary iron normally and iron fortification poses no additional health risk 3

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.